Evaluation of PIVKA-II efficiency in the diagnosis of early hepatocellular carcinoma

被引：0
作者：
Saitta, Carlo [2 ]
Raffa, Giuseppina [2 ]
di Tocco, Francesca Casuscelli [2 ]
Brancatelli, Santa [2 ]
Alibrandi, Angela [3 ]
Raimondo, Giovanni [2 ]
Pollicino, Teresa [1 ]
机构：
[1] Univ Hosp Messina, Pediat Gynecol Microbiol & Biomed Sci, Messina, Italy
[2] Univ Hosp Messina, Clin & Expt Med, Messina, Italy
[3] Univ Messina, Messina, Italy
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1898
引用
收藏
页码：1134A / 1134A
页数：1
相关论文
共 50 条
[31]   ANALYTICAL PERFORMANCE AND METHOD COMPARISON OF THE ELECSYS PIVKA-II IMMUNOASSAY AS AN AID IN DIAGNOSIS OF HEPATOCELLULAR CARCINOMA (HCC) [J].
Chan, Henry Lik Yuen ;
Vogel, Arndt ;
Berg, Thomas ;
De Toni, Enrico N. ;
Kudo, Masatoshi ;
Trojan, Joerg ;
Weinmann, Arndt ;
Eiblmaier, Anja ;
Klein, Hans-Georg ;
Hegel, Johannes Kolja ;
Morgenstern, Dave ;
Madin, Kairat ;
Rolny, Vinzent ;
Lisy, Marcus-Rene ;
Piratvisuth, Teerha .
HEPATOLOGY, 2020, 72 :675A-676A
[32]   Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis (vol 5, pg 292, 2022) [J].
Chan, Henry L. Y. ;
Vogel, Arndt ;
Berg, Thomas ;
De Toni, Enrico N. ;
Kudo, Masatoshi ;
Trojan, Jorg ;
Eiblmaier, Anja ;
Klein, Hanns-Georg ;
Hegel, Johannes Kolja ;
Sharma, Ashish ;
Madin, Kairat ;
Rolny, Vinzent ;
Lisy, Marcus-Rene ;
Piratvisuth, Teerha .
JGH OPEN, 2022, 6 (08) :590-591
[33]   THE VALUE OF COMBINED DETECTION OF PIVKA-II, AFP AND AFP-L3 IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA [J].
Pan, Yongjie ;
Dai, Jinhua ;
Hua, Xin ;
Chew, Junfeng ;
Chew, Yanmin ;
Liao, Yufeng .
ACTA MEDICA MEDITERRANEA, 2019, 35 (05) :2793-2797
[34]   Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA [J].
Wu, Jiali ;
Xiang, Zheyi ;
Bai, Le ;
He, Lagu ;
Tan, Li ;
Hu, Min ;
Ren, Yaping .
CANCER BIOMARKERS, 2018, 23 (02) :235-242
[35]   PIVKA-II [J].
建石良介 ;
韩少良 .
日本医学介绍, 2005, (02) :51-52
[36]   Usefulness of DCP assay method (PIVKA-II IRMA "Daiichi") for hepatocellular carcinoma [J].
Takahashi, Y ;
Shinbata, H ;
Yagi, S ;
Narimatsu, T .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09) :1204-1204
[37]   Clinical significance of PIVKA-II levels after liver transplantation for hepatocellular carcinoma [J].
Villalba, F. ;
Alconchel, F. ;
Saenz, L. ;
Sanchez, M. I. ;
Ferreras, D. ;
Cascales, P. ;
Robles, R. ;
Sanchez-Bueno, F. ;
Ramirez, P. .
TRANSPLANTATION, 2022, 106 (8S) :168-168
[38]   Usefulness of PIVKA-II after Living Donor Liver Transplantation for Hepatocellular Carcinoma [J].
Park, Min-Su ;
Lee, Kwang-Woong ;
Choi, YoungRok ;
Suh, Suk-Won ;
Lee, Jeong-Moo ;
Yi, Nam-Joon ;
Suh, Kyung-Suk .
LIVER TRANSPLANTATION, 2014, 20 :S184-S184
[39]   Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers [J].
An, Shu ;
Zhan, Xiaoxia ;
Liu, Min ;
Li, Laisheng ;
Wu, Jian .
DIAGNOSTICS, 2023, 13 (08)
[40]   The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study [J].
Basile, U. ;
Miele, L. ;
Napodano, C. ;
Ciasca, G. ;
Gulli, F. ;
Pocino, K. ;
De Matthaeis, N. ;
Liguori, A. ;
De Magistris, A. ;
Marrone, G. ;
Biolato, M. ;
Marino, M. ;
Di Giacinto, F. ;
Gasbarrini, A. ;
Grieco, A. ;
Rapaccini, G. L. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (24) :12675-12685
12345